ClinVar Miner

Submissions for variant NM_020631.6(PLEKHG5):c.2564C>T (p.Ser855Leu)

gnomAD frequency: 0.00001  dbSNP: rs768995193
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 3
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Eurofins Ntd Llc (ga) RCV000176113 SCV000227714 uncertain significance not provided 2015-04-14 criteria provided, single submitter clinical testing
Invitae RCV000645441 SCV000767186 uncertain significance Neuronopathy, distal hereditary motor, autosomal recessive 4; Charcot-Marie-Tooth disease recessive intermediate C 2022-08-03 criteria provided, single submitter clinical testing This sequence change replaces serine, which is neutral and polar, with leucine, which is neutral and non-polar, at codon 855 of the PLEKHG5 protein (p.Ser855Leu). This variant is present in population databases (rs768995193, gnomAD 0.007%). This variant has not been reported in the literature in individuals affected with PLEKHG5-related conditions. ClinVar contains an entry for this variant (Variation ID: 195528). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Ambry Genetics RCV002426844 SCV002740243 uncertain significance Inborn genetic diseases 2021-06-17 criteria provided, single submitter clinical testing The p.S855L variant (also known as c.2564C>T), located in coding exon 19 of the PLEKHG5 gene, results from a C to T substitution at nucleotide position 2564. The serine at codon 855 is replaced by leucine, an amino acid with dissimilar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.